Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Fulcrum Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +6 vs. Q4 2022
- Shares held
- 60.4M
- +9.78M (+19.3%) vs. Q4 2022
- Total value
- $172.2M
- −$196.3M (−53.3%) vs. Q4 2022
- New holders
- 27
- 51 more added
- Sold out
- 21
- 22 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 754,886 | $2.15M | 0.00% | +368,054+95.1% | Added |
| State Street Corp | 965,588 | $2.75M | 0.00% | +185,174+23.7% | Added |
| Geode Capital Management, LLC | 1,062,634 | $3.03M | 0.00% | +206,802+24.2% | Added |
| Cormorant Asset Management, LP | 1,081,490 | $3.08M | 0.20% | +1,081,490 | New |
| Morgan Stanley | 1,162,368 | $3.31M | 0.00% | −11,243−1.0% | Reduced |
| VR Adviser, LLC | 1,307,094 | $3.73M | 0.73% | +859,768+192.2% | Added |
| Adage Capital Partners GP, L.L.C. | 1,806,422 | $5.15M | 0.01% | +686,422+61.3% | Added |
| Cowen and Company, LLC | 2,176,045 | $6.20M | 0.73% | +814,876+59.9% | Added |
| TRV GP IV, LLC | 2,343,154 | $6.68M | 4.77% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,643,672 | $7.53M | 0.03% | +2,643,672 | New |
| Vanguard Group Inc | 2,878,491 | $8.20M | 0.00% | +757,868+35.7% | Added |
| BlackRock Inc. | 4,183,738 | $11.9M | 0.00% | +914,747+28.0% | Added |
| Suvretta Capital Management, LLC | 5,177,710 | $14.8M | 0.71% | +902,907+21.1% | Added |
| RTW Investments, LP | 5,511,839 | $15.7M | 0.33% | +518,560+10.4% | Added |
| FMR LLC | 6,156,328 | $17.5M | 0.00% | +922,603+17.6% | Added |
| Ra Capital Management, L.P. | 11,609,704 | $33.1M | 0.75% | +2,103,779+22.1% | Added |
| Logos Global Management LP | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| TRV GP III, LLC | 0 | $0 | 0.00% | −1,962,202−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −768,607−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −631,411−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −206,866−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −193,741−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −185,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −106,600−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −96,152−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −59,100−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −20,994−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −16,073−100.0% | Sold out |
| SVB Financial Group | 0 | $0 | 0.00% | −22,422−100.0% | Sold out |
| SOA Wealth Advisors, LLC. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −660−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −219−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |